Study Overview: Assessing the shift from NaF-PET/CT to PSMA-PET/CT Researchers in Denmark explored whether replacing F-18 sodium fluoride (NaF) PET/CT imaging with F-18 PSMA-PET/CT would influence treatment decisions for men with newly diagnosed, high-risk prostate cancer. The study involved 160 patients who underwent both imaging modalities within a three-week window. Initially, treatment decisions were based…